Biocept Inc: Rises on deal with CLEARED4 to track, manage COVID-19 testing

Biocept

09/06/2021 14:08

** Diagnostics co's shares  BIOC.O  up 5.09% at $4.75
    ** Co partners with pandemic health and safety solutions
firm CLEARED4 to develop a system for tracking and managing
COVID-19 testing requirements and test results for Biocept
customers  urn:newsml:reuters.com:*:nBw6ywjJ8a
    ** Says new service will leverage CLEARED4's health platform
to allow organizations to customize requirements for testing
students, employees and others
    ** Platform will integrate results from BIOC's RT-PCR-based
COVID-19 testing for administrators to monitor on CLEARED4's
real-time dashboard 

 (Reporting by Vishwadha Chander in Bengaluru)
 ((Vishwadha.Chander@thomsonreuters.com;))